# lithium carbonate

NDC: 71610-557
Generic name: lithium carbonate
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20091215

FDA application: ANDA090702

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-557"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-557
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b81eabc-5c5a-4b63-88d4-3f13b45a683e